Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 659

1.

PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.

Kinik ST, Ozbek N, Yuce M, Yazici AC, Verdi H, Ataç FB.

Thromb Haemost. 2008 Feb;99(2):352-6. doi: 10.1160/TH07-06-0395.

PMID:
18278185
2.

The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.

Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, Ozbek N.

Clin Endocrinol (Oxf). 2005 May;62(5):607-10.

PMID:
15853833
3.

Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.

Berberoğlu M, Evliyaoğlu O, Adiyaman P, Ocal G, Ulukol B, Simşek F, Siklar Z, Törel A, Ozel D, Akar N.

J Pediatr Endocrinol Metab. 2006 May;19(5):741-8.

PMID:
16789641
4.

Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.

Sartori MT, Vettor R, De Pergola G, De Mitrio V, Saggiorato G, Della Mea P, Patrassi GM, Lombardi AM, Fabris R, Girolami A.

Thromb Haemost. 2001 Nov;86(5):1161-9.

PMID:
11816701
5.

Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.

Estellés A, Dalmau J, Falcó C, Berbel O, Castelló R, España F, Aznar J.

Thromb Haemost. 2001 Aug;86(2):647-52.

PMID:
11522017
6.

The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.

Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.

Thromb Haemost. 1998 May;79(5):975-9.

PMID:
9609232
7.
8.

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.

Seguí R, Estellés A, Mira Y, España F, Villa P, Falcó C, Vayá A, Grancha S, Ferrando F, Aznar J.

Br J Haematol. 2000 Oct;111(1):122-8.

PMID:
11091191
9.

PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.

Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.

Obesity (Silver Spring). 2006 May;14(5):753-8.

10.

[TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].

Goral J.

Ann Acad Med Stetin. 2008;54(2):14-21. Polish.

PMID:
19374226
11.

The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.

Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E, Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE; HIFMECH Study Group.

J Thromb Haemost. 2003 Nov;1(11):2322-9.

12.

Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study.

Bensen JT, Hsu FC, Brown WM, Sutton BS, Norris JM, Tracy RP, Jenny NS, Saad MF, Haffner S, Bowden DW, Langefeld CD.

Hum Hered. 2004;57(3):128-37.

PMID:
15297806
13.

The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity.

Hoffstedt J, Andersson IL, Persson L, Isaksson B, Arner P.

Diabetologia. 2002 Apr;45(4):584-7.

PMID:
12032637
14.
15.

Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.

Zietz B, Buechler C, Drobnik W, Herfarth H, Schölmerich J, Schäffler A.

Endocr Res. 2004 Aug;30(3):443-53.

PMID:
15554360
17.

Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.

Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.

Ann Hepatol. 2011 Oct-Dec;10(4):493-501.

18.

Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.

Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.

Int J Hematol. 1999 Jan;69(1):43-7.

PMID:
10641442
19.

Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.

Polac I, Stachowiak G, Jedrzejczyk S, Stetkiewics T, Sobieszczanska S, Pertynski T.

Gynecol Endocrinol. 2003 Apr;17(2):151-7.

PMID:
12744226
20.

Relationship between plasma leptin, insulin and tumor necrosis factor alpha in obese children.

Aycan Z, Berberoğlu M, Ocal G, Evliyaoglu O, Adiyaman P, Deda G, Caksen H, Akar N, Karahan C, Cinas P, Bideci A.

J Pediatr Endocrinol Metab. 2005 Mar;18(3):275-84.

PMID:
15813606

Supplemental Content

Support Center